Related Experiment Videos
[Aortic valve replacement using aortic donor valves of human origin]
R B Hokken1, L A van Herwerden, M A Taams
1Afd. Cardiopulmonale Chirurgie, Academisch Ziekenhuis Rotterdam-Dijkzigt.
Nederlands Tijdschrift Voor Geneeskunde
|March 19, 1994
Summary
Aortic valve replacement using cryopreserved aortic allografts demonstrated low hospital mortality and favorable long-term outcomes. Young patients and those with endocarditis particularly benefit from this aortic valve surgery.
Area of Science:
- Cardiovascular Surgery
- Thoracic Surgery
- Transplantation Immunology
Context:
- Aortic valve dysfunction necessitates surgical intervention.
- Cryopreserved aortic allografts offer a biological solution for aortic valve replacement.
- Patient selection criteria, including age and endocarditis, influence allograft suitability.
Purpose:
- To assess the clinical outcomes and safety of aortic valve replacement using cryopreserved aortic allografts.
- To evaluate the efficacy of allografts in patients with specific pathologies like endocarditis and congenital defects.
- To determine the long-term durability and functional status of patients post-allograft aortic valve replacement.
Summary:
- This descriptive clinical study evaluated 68 patients undergoing aortic valve replacement with cryopreserved aortic allografts between 1988 and 1993.
- Hospital mortality was 4%, with a mean follow-up of 22 months. 91% of patients achieved New York Heart Association class I functional status.
- Six patients (9%) required reoperation, primarily among the initial cohort, with minimal late valve-related events reported.
Impact:
- Aortic valve replacement with allografts is associated with low hospital mortality and good functional recovery.
- Cryopreserved aortic allografts are a viable option, especially for younger patients and those with endocarditis.
- Prioritizing allograft allocation for high-risk groups may optimize surgical outcomes and resource utilization.